Adjunct VR Pain Management in Acute Brain Injury
Purpose
Severe and refractory pain after acute injury is a known-risk factor for chronic opioid use disorder. In this study, the investigators will use Virtual Reality (VR) immersion as a non-pharmacological adjunct to treat pain associated with acute traumatic injuries, including traumatic brain injury. The investigators hypothesize that VR therapy will decrease pain and reduce opioid use in patients with acute traumatic injuries, including TBI.
Conditions
- Traumatic Brain Injury
- Headaches Posttraumatic
- Trauma
- Pain, Acute
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Diagnosis of Traumatic Injury (including but not limited to traumatic brain injury) - Age greater than or equal to 18 years-old - Endorsing at least moderate pain as defined by documentation of at least one numeric rating pain scale score of 3 or more in the last 24 hours. - Glasgow Coma Scale of 15 - Expected to stay in the hospital for at least 12 hours after enrollment
Exclusion Criteria
- Seizure prior to enrollment - Pregnancy - non-English speaking - Known intolerance of Virtual Reality - Patient unable to consent for themselves
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover Assignment
- Intervention Model Description
- Within-Subjects Design
- Primary Purpose
- Treatment
- Masking
- Single (Care Provider)
- Masking Description
- Interventions will take place in patient rooms with curtain pulled and sign to mask active intervention vs. control intervention from care providers.
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Virtual Reality Sessions |
All participants will participate in virtual reality sessions. |
|
|
Active Comparator Comparator Sessions |
All participants will participate in tablet-based sessions to content-less sessions wearing the virtual reality headset |
|
More Details
- Status
- Completed
- Sponsor
- University of Maryland, Baltimore
Study Contact
Detailed Description
Each participant will undergo one VR session and two control sessions. The VR session will take place in a commercially available VR environment, the Blu, and last 20-30 minutes. The environment is based upon literature reviews on chromotherapy. The control sessions will include a 2D-tablet based session that mimics the VR content and a content-less placement of the VR headset. The order of these sessions will be randomized across patients. Each participant will complete a pre-study questionnaire to elicit their prior experience with the virtual reality as well as measures of gaming addiction/engagement, boredom, and expectancy. These scales will help us determine which patient-level factors predict response to VR. Before and after each session, participants will complete validated scales of pain, nausea, and anxiety.. Pre- and Post-VR opioid use will be recorded. Basic vital signs including heart rate, blood pressure, and respiratory rate, will be recorded before and after each session to monitor autonomic response. Advanced measures of autonomic response will include heart rate variability,,and pupillometry metrics. At the conclusion of all sessions, participants will complete another questionnaire to document their subjective experience of using VR.